CIID is a research and development center found in 2017 to support the Innovation Hub-Ageing Society project, which is dedicated to building innovation-based economy in alignment with the Thailand 4.0's policy. The establishment of this center is a collaborative effort between Biomedical Technology Research Center and Center of Biomolecular Therapy and Diagnostic, which possess exceptional expertise in the development of immunodiagnostic kits across the upstream, midstream, and downstream stages, in addition to extensive experience in manufacturing commercial diagnostic kits
The researchers at CIID acknowledge the importance of research, development, and production of diagnostic kits in various formats, to facilitate the diagnosis of major diseases impacting the health of Thai population. With this awareness, our center is committed to continuous improvement of our operations to meet the international standards, to support the manufacturing of high-performance diagnostic products that meet the requirements for commercialization. Our goal is for CIID to serve as a one-stop hub for the diagnostic technology development, with active participation in various areas such as knowledge accumulation, skilled workforce training, establishment of management and production systems, and collaboration between academia and the private sector, both domestically and internationally.
ISO13485:2016 & EN ISO13485:2016, with the following scope: “The manufacture of antibody and conjugation of antibody-colloidal gold for in-vitro diagnostic test kits for lateral-flow immunoassay”
This immunochromatographic strip test enables rapid detection of Hb Bart's in red blood cells, utilizing a specific monoclonal antibody for Hb Bart's capture. It is suitable for the screening of alpha-thalassemia 1 carriers, and has been certified with ISO 13485.
+66 5393 5070
Center of Innovative Immunodiagnostic Development (CIID)
Building 1, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200